Liberty Health Sciences Reports 2020 Second Quarter Financial Results

Note: All references to dollar values refer to Canadian dollars unless otherwise stated.

TORONTO, Oct. 31, 2019 /PRNewswire/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of high quality cannabis, announced its financial results for the second quarter ended August 31, 2019. Consolidated net sales for the quarter ended August 31, 2019 were $10,627,656, compared with $2,219,290 for the quarter ended August 31, 2018 and $16,148,217 for the six-months ended August 31, 2019, compared with $3,360,408 for the six months ended August 31, 2018.

The significant year-over-year increase in revenue was driven by the Company’s opening of new dispensaries and delivery locations, as well as experiencing an upsurge in same store sales volume and an uptick in the registered patient base for Medical Marijuana Use in Florida.

The Company recorded net income for the quarter ended August 31, 2019 of $22,884,261, compared with a net loss of $5,605,355 for the quarter ended August 31, 2018.

As of August 31, 2019, Liberty maintained $23,884,434 of cash and term deposits compared to $13,291,426 in cash and term deposits at February 28, 2019.

Liberty’s product offerings include eight outstanding quality brands including Liberty Health Sciences, Zentient, Pretty Pistil, Papa’s Herb, Mary’s Medicinal, PAX, Werc Shop, and Lemon and Grass.

As one of the first companies in Florida to rollout whole flower products in all of its dispensaries, Liberty has reached monthly sales, including smokable medical marijuana, of more than $4.6 million in August 2019. The Company expects its sales to continue to grow steadily as it expands its dispensary footprint and product offerings.

In support of the ongoing opening of Liberty dispensary locations paving the way for future growth, Liberty finished construction on its new 387-acre state-of-the-art Liberty-360 facility comprising of 300,000 square feet of greenhouse processing and production space resulting in the Company being the lowest cost and consistent producer in Florida.

The second quarter of fiscal year 2020 proved to be the largest sales revenue quarter in the history of our Company. Liberty’s continued growth directly ties to the strategic initiatives we have set in place, which has been increasing our Florida production, retail base and delivery footprint along with expanding our product portfolio and brand partnerships.

Victor Mancebo, Interim Chief Executive Officer of Liberty

We continue to work on numerous marketing strategies that will complement our expansion plans and simultaneously provide our patients a more educational, personalized and accessible experience.

Liberty currently operates 19 dispensaries across Florida in the following locations:

Dania Beach

Port St. Lucie

Miami

Summerfield

Palm Harbor

Orange Park

St. Petersburg

Gainesville

Tampa (Hyde Park)

Cape Coral

Winter Haven

Boca Raton

Merritt Island

Bonita Springs

Tallahassee

Panama City

North Miami

Tampa (Tetra)

Pensacola

Operational Highlights:

Liberty has opened 19 dispensaries to date throughout Florida, with 16 dispensaries opened by quarter end.

The Company has lease agreements in place for another 10 locations and is further negotiating another seven.

In June 2019, Liberty introduced Zentient to all of its dispensaries as its new house brand of products along with Pretty Pistil. Zentient represents a line of premium CBD and THC balanced products including topicals, vapes, and oral solutions made from a proprietary formula of ultra-high-quality cannabinoids.

The Company entered into an in-licensed agreement with The Werc Shop in June 2019 for its patented and patent-pending terpene technology. The Werc Shop is a world-renowned scientific consulting group recognized as the leaders in cannabis terpene analysis and terpene-based formulations.

In August 2019, the Company sold its Chestnut Hill Tree Farm site in Alachua County, Florida, as well as all its assets in Ohio.

About Liberty Health Sciences Inc.

Liberty is the cannabis provider committed to providing a high-quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale. For more information, please visit: www.libertyhealthsciences.com

Original press release

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch